Strategic Partnerships Leverage Enzymotec's established Frutarom affiliation and joint ventures such as InFat with AAK to explore co-development or distribution agreements for infant nutrition and specialized lipid ingredients in new regional markets.

Expansion Opportunities Target health-focused nutraceutical and medical food players looking to expand lipid-based ingredient portfolios, especially in cardiovascular and neurological segments where VAYA Pharma products already address unmet needs.

Product Differentiation Highlight proprietary lipid ingredients like K-Real krill oil and SharpPS to premium brands seeking clinically supported, brain-health and infant-formula fat solutions to differentiate their offerings.

Market Readiness Position Enzymotec’s two-segment structure as a one-stop shop for nutrition and medical foods, appealing to manufacturers seeking streamlined sourcing, regulatory alignment, and end-to-end lipid-based product development.

Growth Signals Capitalize on ongoing brand acquisitions and licensing partnerships (for example Hellenia licensing K.Real) to identify potential distribution partners and contract manufacturers in regions with emerging demand for advanced lipid ingredients.